# Relevance of Notch Signaling for Bone Metabolism and Regeneration

**Authors:** Tobias M. Ballhause, Shan Jiang, Anke Baranowsky, Sabine Brandt, Peter R. Mertens, Karl-Heinz Frosch, Timur Yorgan, Johannes Keller

PMC · DOI: 10.3390/ijms22031325 · 2021-01-29

## TL;DR

This review explores how the Notch signaling pathway influences bone metabolism, regeneration, and related disorders.

## Contribution

The paper provides a comprehensive overview of Notch signaling's role in bone biology and its interactions with other pathways.

## Key findings

- Notch receptors regulate osteoblast and osteoclast activity during bone remodeling.
- Notch signaling interacts with Wnt/β-catenin, BMP, and RANKL/OPG pathways in bone turnover.
- Mutations in Notch genes are linked to congenital and degenerative skeletal disorders.

## Abstract

Notch1-4 receptors and their signaling pathways are expressed in almost all organ systems and play a pivotal role in cell fate decision by coordinating cell proliferation, differentiation and apoptosis. Differential expression and activation of Notch signaling pathways has been observed in a variety of organs and tissues under physiological and pathological conditions. Bone tissue represents a dynamic system, which is constantly remodeled throughout life. In bone, Notch receptors have been shown to control remodeling and regeneration. Numerous functions have been assigned to Notch receptors and ligands, including osteoblast differentiation and matrix mineralization, osteoclast recruitment and cell fusion and osteoblast/osteoclast progenitor cell proliferation. The expression and function of Notch1-4 in the skeleton are distinct and closely depend on the temporal expression at different differentiation stages. This review addresses the current knowledge on Notch signaling in adult bone with emphasis on metabolism, bone regeneration and degenerative skeletal disorders, as well as congenital disorders associated with mutant Notch genes. Moreover, the crosstalk between Notch signaling and other important pathways involved in bone turnover, including Wnt/β-catenin, BMP and RANKL/OPG, are outlined.

## Linked entities

- **Genes:** NOTCH1 (notch receptor 1) [NCBI Gene 4851], NOTCH2 (notch receptor 2) [NCBI Gene 4853], NOTCH3 (notch receptor 3) [NCBI Gene 4854], NOTCH4 (notch receptor 4) [NCBI Gene 4855]
- **Proteins:** dpp (decapentaplegic), TNFSF11 (TNF superfamily member 11), BTF3P11 (basic transcription factor 3 pseudogene 11)

## Full-text entities

- **Genes:** Hey1 (hairy/enhancer-of-split related with YRPW motif 1) [NCBI Gene 15213] {aka CHF2, HRT1, Herp2, Hesr1, bHLHb31, hesr-1}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], Dll1 (delta like canonical Notch ligand 1) [NCBI Gene 13388] {aka Delta1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Smad3 (SMAD family member 3) [NCBI Gene 17127] {aka Madh3}, Egf (epidermal growth factor) [NCBI Gene 13645], CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, Hey2 (hairy/enhancer-of-split related with YRPW motif 2) [NCBI Gene 15214] {aka CHF1, Herp1, Hrt2, bHLHb32, hesr2}, Hes1 (hes family bHLH transcription factor 1) [NCBI Gene 15205] {aka Hry, bHLHb39}, Fbxw7 (F-box and WD-40 domain protein 7) [NCBI Gene 50754] {aka 1110001A17Rik, AGO, Cdc4, Fbw7, Fbwd6, Fbx30}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, Gdf2 (growth differentiation factor 2) [NCBI Gene 12165] {aka Bmp9}, Tnfsf11 (tumor necrosis factor (ligand) superfamily, member 11) [NCBI Gene 21943] {aka Ly109l, ODF, OPGL, RANKL, Trance}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}, Runx2 (runt related transcription factor 2) [NCBI Gene 12393] {aka AML3, CBF-alpha-1, Cbf, Cbfa-1, Cbfa1, LS3}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, JAG1 (jagged canonical Notch ligand 1) [NCBI Gene 182] {aka AGS, AGS1, AHD, AWS, CD339, CMT2HH}, BTF3P11 (basic transcription factor 3 pseudogene 11) [NCBI Gene 690] {aka BRF3L1, BTF3L1, HUMBTFB, OCIF, OPG, TNFRSF11B}, Dll4 (delta like canonical Notch ligand 4) [NCBI Gene 54485] {aka Delta4}, DLL3 (delta like canonical Notch ligand 3) [NCBI Gene 10683] {aka SCDO1}, NOTCH3 (notch receptor 3) [NCBI Gene 4854] {aka CADASIL, CADASIL1, CARASIL1, CASIL, FPLD1, IMF2}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, Smad4 (SMAD family member 4) [NCBI Gene 17128] {aka D18Wsu70e, DPC4, Madh4}, N (Notch) [NCBI Gene 31293] {aka 1.1, 16-178, 16-55, Ax, CG3936, CT13012}, TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600] {aka CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, PDPN (podoplanin) [NCBI Gene 10630] {aka AGGRUS, D2-40, GP36, GP40, Gp38, HT1A-1}, Notch1-4 [NCBI Gene 4851;4853;4854;4855], ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, NOTCH2 (notch receptor 2) [NCBI Gene 4853] {aka AGS2, HJCYS, hN2}, Rbpj (recombination signal binding protein for immunoglobulin kappa J region) [NCBI Gene 19664] {aka CBF1, Igkjrb, Igkrsbp, RBP-J, RBP-J kappa, RBP-Jkappa}, Nfatc1 (nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1) [NCBI Gene 18018] {aka 2210017P03Rik, NF-ATc, NFAT2, NFATc, Nfatcb}, Notch3 (notch 3) [NCBI Gene 18131] {aka N3, hpbk}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, Notch1 (notch 1) [NCBI Gene 18128] {aka 9930111A19Rik, Mis6, N1, Tan1, lin-12}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, Notch3 (notch receptor 3) [NCBI Gene 56761], DLL4 (delta like canonical Notch ligand 4) [NCBI Gene 54567] {aka AOS6, delta4, hdelta2}, Prdx1 (peroxiredoxin 1) [NCBI Gene 18477] {aka MSP23, NkefA, OSF-3, OSF3, PAG, Paga}, Bglap (bone gamma-carboxyglutamate protein) [NCBI Gene 25295] {aka Bglap2, Bgp, Bgpr, Bgpra}, GDF2 (growth differentiation factor 2) [NCBI Gene 2658] {aka BMP-9, BMP9, HHT5}, TNFRSF11B (TNF receptor superfamily member 11b) [NCBI Gene 4982] {aka OCIF, OPG, PDB5, TR1}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, NOTCH4 (notch receptor 4) [NCBI Gene 4855] {aka INT3}, SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, Tnfrsf11b (tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)) [NCBI Gene 18383] {aka OCIF, Opg, TR1}, Runx2 (RUNX family transcription factor 2) [NCBI Gene 367218] {aka CBF-alpha-1, Cbfa1, OSF-2}, SP7 (Sp7 transcription factor) [NCBI Gene 121340] {aka OI11, OI12, OSX, osterix}, ANK1 (ankyrin 1) [NCBI Gene 286] {aka ANK, SPH1, SPH2, ankyrin-1}, Nfatc1 (nuclear factor of activated T-cells 1) [NCBI Gene 100361818], Notch2 (notch 2) [NCBI Gene 18129] {aka N2}, FLT1 (fms related receptor tyrosine kinase 1) [NCBI Gene 2321] {aka FLT, FLT-1, VEGFR-1, VEGFR1}, Csf1 (colony stimulating factor 1) [NCBI Gene 78965] {aka PG-M-CSF}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, Tnfsf11 (TNF superfamily member 11) [NCBI Gene 117516] {aka ODF, OPGL, RANKL, TRANCE}, RBPJ (recombination signal binding protein for immunoglobulin kappa J region) [NCBI Gene 3516] {aka AOS3, CBF-1, CBF1, IGKJRB, IGKJRB1, KBF2}
- **Diseases:** facial anomalies (MESH:C557821), osteoid (MESH:D010017), subcortical infarcts (MESH:D002544), heart malformations (MESH:D006330), osteopenia (MESH:D001851), cranioskeletal dysplasia (MESH:D015792), cancer (MESH:D009369), genetic disorder (MESH:D030342), liver disease (MESH:D008107), hypotonia (MESH:D009123), sepsis (MESH:D018805), osteoporotic (MESH:D058866), ACC (MESH:D004476), vertebral abnormalities (MESH:C535781), ophthalmologic abnormalities (MESH:C536647), bone resorption (MESH:D001862), hairy (MESH:D007943), leukoencephalopathy (MESH:D056784), skeletal dysplasia (MESH:C535858), skeletal disorder (MESH:C564967), migraine (MESH:D008881), resorption (MESH:D014091), meningocele (MESH:D008588), congenital disorders (MESH:D009358), inflammatory (MESH:D007249), developmental delay (MESH:D002658), cerebral microangiopathy (MESH:D059345), cranial ossification defects (MESH:C563592), absence of fingers and (MESH:D004832), transverse limb defects (MESH:C537446), sarcopenia (MESH:D055948), long bone deformities (MESH:D050398), osteodysplasia (MESH:C538271), dementia (MESH:D003704), Renal abnormalities (MESH:D007674), Cardiac malformations (MESH:D006331), strokes (MESH:D020521), abnormalities of the extremities (MESH:D003638), neurological deficits (MESH:D009461), bone turnover (MESH:D001847), Alagille Syndrome (MESH:D016738), scoliosis (MESH:D012600), HCS (MESH:D031845), Cardiovascular malformations (MESH:D018376), morphological abnormality of the bile ducts (MESH:D001649), gastrointestinal side effects (MESH:D064420), pulmonary hypertension (MESH:D006976), acro-osteolysis (MESH:D030981), microangiopathy (MESH:D014652), joint hypermobility (MESH:D007593), skin defects (MESH:D012868), LMS (MESH:C537878), cerebral autosomal dominant arteriopathy (MESH:D020943), terminal (MESH:D007153), CADASIL (MESH:D046589), osteosclerosis (MESH:D010026), Hypoxia (MESH:D000860), hemorrhage (MESH:D006470), Chiari type 1 malformation (MESH:D001139), bone marrow toxicity (MESH:D001855)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Danio rerio (leopard danio, species) [taxon 7955], Adenoviridae (family) [taxon 10508], Drosophila melanogaster (fruit fly, species) [taxon 7227], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** ST-2 — Mus musculus (Mouse), Stromal cell line (CVCL_2205), C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC7865281/full.md

---
Source: https://tomesphere.com/paper/PMC7865281